Consolidated Statement of Cash Flows for the period from January 1 to June 30, 2023
T023 | |||
in EUR thousand | Note | H1 2023 | H1 2022 |
---|---|---|---|
Operating activities | |||
Result for the period | 18,337 | 26,699 | |
Depreciation and amortization | 39,570 | 39,454 | |
Gain (–) / loss (+) on disposal of property, plant and equipment | -116 | -1,746 | |
Change in provisions | 221 | -737 | |
Change in deferred taxes | -3,408 | -5,483 | |
Change in inventories, trade receivables and other assets not attributable to investing or financing activities | -33,758 | -73,663 | |
Change in trade payables and other liabilities not attributable to investing or financing activities | -36,490 | 14,728 | |
Change in liabilities from reverse factoring programs | 343 | 3,273 | |
Disbursements for share-based payments | -530 | -578 | |
Interest expenses for the period | 9,634 | 4,880 | |
Income (–) / expenses (+) from the measurement of derivatives | 1,436 | 2,415 | |
Other non-cash expenses (+) / income (–) | -2,298 | -2,100 | |
Cash inflow from operating activities | (18) | -7,059 | 7,142 |
thereof from interest received | 537 | 243 | |
thereof from income taxes | -15,345 | -13,464 | |
Investing activities | |||
Acquisition of intangible assets and property, plant and equipment | -32,047 | -21,385 | |
Proceeds from the sale of property, plant and equipment | 724 | 6,828 | |
Cash outflow for investing activities | (18) | -31,323 | -14,557 |
Financing activities | |||
Interest paid | -7,967 | -3,394 | |
Dividends paid to shareholders | (14) | -17,524 | -23,897 |
Dividends distributed to non-controlling interests | (14) | 0 | -140 |
Proceeds from loans | 13,250 | 18,402 | |
Repayment of loans | (13) | -8,961 | -13,259 |
Proceeds from / repayment of hedging derivatives | (13) | -990 | -269 |
Repayment of lease liabilities | -6,056 | -7,523 | |
Cash outflow / inflow from financing activities | (18) | -28,248 | -30,080 |
Net change in cash and cash equivalents | -66,630 | -37,495 | |
Cash and cash equivalents at the beginning of the fiscal year | 168,670 | 185,719 | |
Effects of foreign exchange rates on cash and cash equivalents | -2,725 | 6,877 | |
Cash and cash equivalents at the end of the period | (18) | 99,315 | 155,101 |
Condensed Notes to the Consolidated Financial Statements